Search

Daniel R. Carcanague

Examiner (ID: 5382, Phone: (571)270-3023 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1621, 1625
Total Applications
1087
Issued Applications
878
Pending Applications
22
Abandoned Applications
208

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17800126 [patent_doc_number] => 11414406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Antagonists of the muscarinic acetylcholine receptor M [patent_app_type] => utility [patent_app_number] => 16/966306 [patent_app_country] => US [patent_app_date] => 2019-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966306 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/966306
Antagonists of the muscarinic acetylcholine receptor M Jan 31, 2019 Issued
Array ( [id] => 16628647 [patent_doc_number] => 20210047300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => HETERO RING-FUSED PHENYL COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/967825 [patent_app_country] => US [patent_app_date] => 2019-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967825 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/967825
Hetero ring-fused phenyl compounds for inhibiting TNIK and medical uses thereof Jan 30, 2019 Issued
Array ( [id] => 15363481 [patent_doc_number] => 20200017505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => NITROGEN-CONTAINING HETEROCYCLIC AMIDE COMPOUND AND PHARMACEUTICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/261792 [patent_app_country] => US [patent_app_date] => 2019-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33832 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16261792 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/261792
Nitrogen-containing heterocyclic amide compound and pharmaceutical use thereof Jan 29, 2019 Issued
Array ( [id] => 17407128 [patent_doc_number] => 11247997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => Compound and preparation and application thereof [patent_app_type] => utility [patent_app_number] => 16/480674 [patent_app_country] => US [patent_app_date] => 2019-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 30 [patent_no_of_words] => 26389 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480674 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/480674
Compound and preparation and application thereof Jan 27, 2019 Issued
Array ( [id] => 14715437 [patent_doc_number] => 20190248782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => METHOD FOR PREPARING MARAVIROC [patent_app_type] => utility [patent_app_number] => 16/257987 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2179 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16257987 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/257987
Method for preparing Maraviroc Jan 24, 2019 Issued
Array ( [id] => 18102384 [patent_doc_number] => 11542259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-03 [patent_title] => Compounds for the treatment of kinase-dependent disorders [patent_app_type] => utility [patent_app_number] => 16/964330 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69939 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964330 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964330
Compounds for the treatment of kinase-dependent disorders Jan 24, 2019 Issued
Array ( [id] => 17996665 [patent_doc_number] => 11497751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-15 [patent_title] => Modulators of Rho-associated protein kinase [patent_app_type] => utility [patent_app_number] => 16/964904 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80057 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 518 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964904 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964904
Modulators of Rho-associated protein kinase Jan 24, 2019 Issued
Array ( [id] => 16657344 [patent_doc_number] => 20210053980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-25 [patent_title] => Use of Pyridoxal Acetal Salts as Water-Triggered Profragrances [patent_app_type] => utility [patent_app_number] => 16/964804 [patent_app_country] => US [patent_app_date] => 2019-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964804 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964804
Use of pyridoxal acetal salts as water-triggered pro-fragrances Jan 23, 2019 Issued
Array ( [id] => 16613558 [patent_doc_number] => 20210032211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => PROCESSES FOR THE SYNTHESIS OF SULFENTRAZONE [patent_app_type] => utility [patent_app_number] => 16/962834 [patent_app_country] => US [patent_app_date] => 2019-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3962 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962834 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/962834
PROCESSES FOR THE SYNTHESIS OF SULFENTRAZONE Jan 17, 2019 Abandoned
Array ( [id] => 15726705 [patent_doc_number] => 10611773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-07 [patent_title] => Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B [patent_app_type] => utility [patent_app_number] => 16/246999 [patent_app_country] => US [patent_app_date] => 2019-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 54551 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246999 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/246999
Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B Jan 13, 2019 Issued
Array ( [id] => 15853753 [patent_doc_number] => 10642155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Mixed-type photosensitive resin and preparation method therefor [patent_app_type] => utility [patent_app_number] => 16/246379 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4555 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16246379 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/246379
Mixed-type photosensitive resin and preparation method therefor Jan 10, 2019 Issued
Array ( [id] => 17756211 [patent_doc_number] => 11396495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-26 [patent_title] => Amine compound for inhibiting SSAO/VAP-1 and use thereof [patent_app_type] => utility [patent_app_number] => 16/770474 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44951 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770474 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/770474
Amine compound for inhibiting SSAO/VAP-1 and use thereof Dec 27, 2018 Issued
Array ( [id] => 17875489 [patent_doc_number] => 11447490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereof [patent_app_type] => utility [patent_app_number] => 16/964551 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1492 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964551 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964551
Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereof Dec 27, 2018 Issued
Array ( [id] => 16359381 [patent_doc_number] => 20200316132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-08 [patent_title] => COMPOSITIONS AND METHODS FOR WILLIAMS SYNDROME (WS) THERAPY [patent_app_type] => utility [patent_app_number] => 16/955958 [patent_app_country] => US [patent_app_date] => 2018-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40268 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955958 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955958
Compositions and methods for Williams Syndrome (WS) therapy Dec 20, 2018 Issued
Array ( [id] => 15512631 [patent_doc_number] => 10562891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-18 [patent_title] => Quinazolinones as PARP14 inhibitors [patent_app_type] => utility [patent_app_number] => 16/227132 [patent_app_country] => US [patent_app_date] => 2018-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 53363 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16227132 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/227132
Quinazolinones as PARP14 inhibitors Dec 19, 2018 Issued
Array ( [id] => 16533271 [patent_doc_number] => 10875854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-29 [patent_title] => Triazolopyridines [patent_app_type] => utility [patent_app_number] => 16/224507 [patent_app_country] => US [patent_app_date] => 2018-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9657 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16224507 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/224507
Triazolopyridines Dec 17, 2018 Issued
Array ( [id] => 14963025 [patent_doc_number] => 20190308990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => COMPOUNDS AND COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/214985 [patent_app_country] => US [patent_app_date] => 2018-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16214985 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/214985
Compounds and compositions and uses thereof Dec 9, 2018 Issued
Array ( [id] => 14158673 [patent_doc_number] => 20190106439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-11 [patent_title] => HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER [patent_app_type] => utility [patent_app_number] => 16/214573 [patent_app_country] => US [patent_app_date] => 2018-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31115 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -55 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16214573 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/214573
HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER Dec 9, 2018 Abandoned
Array ( [id] => 17029692 [patent_doc_number] => 11091497 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-17 [patent_title] => Pyrano[3,4-b]pyrazine kappa opioid receptor ligands for treating addiction, pruritus, pain, and inflammation [patent_app_type] => utility [patent_app_number] => 16/769858 [patent_app_country] => US [patent_app_date] => 2018-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12669 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769858 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/769858
Pyrano[3,4-b]pyrazine kappa opioid receptor ligands for treating addiction, pruritus, pain, and inflammation Dec 6, 2018 Issued
Array ( [id] => 16169461 [patent_doc_number] => 10711009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Method of preparing d-glucaro-1,4:6,3-dilactone [patent_app_type] => utility [patent_app_number] => 16/213461 [patent_app_country] => US [patent_app_date] => 2018-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 3901 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16213461 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/213461
Method of preparing d-glucaro-1,4:6,3-dilactone Dec 6, 2018 Issued
Menu